Clinical Trial Update: Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on second-line therapy for advanced intrahepatic cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: UNKNOWN